Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,256,228 papers from all fields of science
Search
Sign In
Create Free Account
nabumetone
Known as:
Nabumetona
, 4-(6-methoxy-2-naphthyl)-2-butanone
, Nabumétone
Expand
A naphthylalkanone and non-steroidal anti-inflammatory drug (NSAID) with anti-inflammatory, antipyretic and analgesic activities. Nabumetone is a…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
15 relations
Narrower (4)
BRL 14777
Relafen
Relif
Relifex
Broader (2)
Butanones
Cyclooxygenase 2 Inhibitors
Degenerative polyarthritis
Drug Allergy
Inflammation
Liver diseases
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Determining the Molecular Pathways Underlying the Protective Effect of Non-Steroidal Anti-Inflammatory Drugs for Alzheimer's Disease: A Bioinformatics Approach
A. Nevado-Holgado
,
S. Lovestone
Computational and Structural Biotechnology…
2016
Corpus ID: 15012468
2013
2013
Role of carbonyl reducing enzymes in the phase I biotransformation of the non-steroidal anti-inflammatory drug nabumetone in vitro
Lucie Škarydová
,
M. Nobilis
,
V. Wsól
Xenobiotica; the fate of foreign compounds in…
2013
Corpus ID: 31437860
1. Nabumetone is a clinically used non-steroidal anti-inflammatory drug, its biotransformation includes major active metabolite 6…
Expand
Review
2004
Review
2004
Spontaneous Reports of Hypertension Leading to Hospitalisation in Association with Rofecoxib, Celecoxib, Nabumetone and Oxaprozin
A. Brinker
,
L. Goldkind
,
R. Bonnel
,
J. Beitz
Drugs & Aging
2004
Corpus ID: 41407837
Background and objectiveData on file with the US FDA, and other published studies, suggest that the selective cyclo-oxygenase…
Expand
Review
2002
Review
2002
Dose-effect relationships of nonsteroidal anti-inflammatory drugs: a literature review.
P. Emery
,
S. Kong
,
E. Ehrich
,
D. Watson
,
T. Towheed
Clinical Therapeutics
2002
Corpus ID: 3364039
Review
2001
Review
2001
The ever-emerging anti-inflammatories. Have there been any real advances?
K. Rainsford
Journal of Physiology - Paris
2001
Corpus ID: 21440382
2001
2001
Distal bowel selectivity in the chemoprevention of experimental colon carcinogenesis by the non‐steroidal anti‐inflammatory drug nabumetone
H. Roy
,
W. Karolski
,
Anne Ratashak
International Journal of Cancer
2001
Corpus ID: 1051665
Use of non‐steroidal anti‐inflammatory drugs (NSAIDs) for chemoprevention of colon cancer has been hindered by their potential…
Expand
1995
1995
Gastroduodenal tolerability of nabumetone versus naproxen in the treatment of rheumatic patients.
G. Bianchi porro
,
F. Montrone
,
M. Petrillo
,
I. Caruso
,
V. Imbesi
American Journal of Gastroenterology
1995
Corpus ID: 6005541
OBJECTIVE The objective of this endoscopic, double-blind study was to evaluate the gastric tolerability of nabumetone, a novel…
Expand
1994
1994
Comparative Effects of Nabumetone, Sulindac, and Indomethacin on Urinary Prostaglandin Excretion and Platelet Function in Volunteers
M. Freed
,
P. Audet
,
+7 authors
D. Jorkasky
Journal of clinical pharmacology
1994
Corpus ID: 34082813
Nonsteroidal antiinflammatory drugs differ with respect to their effects on prostaglandin metabolism in various tissues, a…
Expand
1994
1994
A longterm endoscopic evaluation of patients with arthritis treated with nabumetone vs naproxen.
S. Roth
,
R. Bennett
,
P. Caldron
,
C. Mitchell
,
C. Swenson
,
R. Koepp
Journal of Rheumatology
1994
Corpus ID: 32464919
OBJECTIVE To compare the gastrointestinal safety, ulcerogenic potential, and clinical efficacy over 5 years of nabumetone and…
Expand
1992
1992
Worldwide safety experience with nabumetone.
Bernhard Gc
1992
Corpus ID: 54154229
Nabumetone has undergone human clinical premarketing and postmarketing testing for efficacy and safety for about 10 years. In the…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE